Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
$ 4.41MEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)
VS
Market
Sector
Industry
History
$ 12.4Close
$ 6.3 - $ 178.5 52-Week Range
Ticker Information
Ticker
BCTXCompany Name
BRIACELL THERAPEUTICS CORPSector
HealthcareIndustry
BiotechnologyExchange
NASDAQBRIACELL THERAPEUTICS CORP - Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
BCTX - EBITDA Historical data
| Date | Depreciation, Amortization & Accretion | Earning Before Interest & Taxes (EBIT) | Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) |
|---|---|---|---|
| 3/31/2025 | $ 152.41K | $ 4.26M | $ 4.41M |
| 12/31/2024 | $ 129.57K | $ 1.13M | $ 1.26M |
| 9/30/2024 | $ 106.74K | $ -2.31M | $ -2.21M |
| 6/30/2024 | $ 83.9K | $ -4.93M | $ -4.85M |
| 3/31/2024 | $ 15.27K | $ -20.8M | $ -20.78M |
| 12/31/2023 | $ 15.27K | $ -17.23M | $ -17.21M |
| 9/30/2023 | $ 15.27K | $ -11.87M | $ -11.85M |
| 6/30/2023 | $ 15.27K | $ -23.27M | $ -23.26M |
| 3/31/2023 | $ 17.91K | $ -18.02M | $ -18M |
| 12/31/2022 | $ 17.03K | $ -16.07M | $ -16.05M |
Key Performance Insights, Last 5 Years
- BRIACELL THERAPEUTICS CORP's latest trailing twelve months (TTM) EBITDA stands at $ -3.76M.
- Over the past 5 years, BRIACELL THERAPEUTICS CORP's average EBITDA has been $ -9.4M.
- The median EBITDA for BRIACELL THERAPEUTICS CORP during this period was $ -11.11M
- BRIACELL THERAPEUTICS CORP reached its highest EBITDA over the past 5 years at $ 4.41M.
- The lowest EBITDA recorded by BRIACELL THERAPEUTICS CORP in the same timeframe $ -23.26M
Similar metrics to EBITDA:
- Depreciation, Amortization & Accretion - [Cash Flow Statement] A component of operating cash flow [NCFO] representing the aggregate net amount of depreciation, amortization, and accretion recognized during an accounting period. As a non-cash item, the net amount is added back to net income when calculating cash provided by operations.
- Enterprise Value over EBITDA - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its earnings before interest, taxes, depreciation, and amortization [EBITDA].
- EBITDA per Share - [Calculation] The amount of earnings before interest, taxes, depreciation, and amortization attributed to each share, calculated as [EBITDA] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- Earning Before Interest & Taxes (EBIT) - [Income Statement] Earnings before interest and taxes measures a company's net income [NetInc] prior to the deduction of interest [IntExp] and tax expenses [TaxExp].
- EBITDA Margin - [Calculation] A company’s [EBITDA] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest, taxes, depreciation and amortization.
Definition of Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)
[Calculation] EBITDA is a non-GAAP accounting metric that lets investors asses profitability net of expenses dependent on financing decision, tax strategy and depreciation schedules. It is calculated by adding depreciation and amortisation expenses [DepAmor] back to [EBIT].EBIT + DepAmor
(=) EBITDA EBITDA for BRIACELL THERAPEUTICS CORP is calculated as follows: EBIT [ $ -3.78M ] + DepAmor [ $ 14.43K ]
(=) EBITDA [ $ -3.76M ] BCTX - Earnings Before Interest Taxes & Depreciation Amortization (EBITDA), Last 5 years
$ -23.26M
Minimum
Jun 30, 2023
$ 4.41M
Maximum
Mar 31, 2025
$ -9.4M
Average
$ -11.11M
Median
EBITDA Benchmark AnalysisMarket
The chart above depicts the distribution of EBITDA for companies in the Total Stock Market. The average EBITDA of the companies is $ 58.9M with a standard deviation of $ 167.01M.
The following table provides additional summary stats:
EBITDA in the Market:
| filtered constituents | 3.24K |
|---|---|
| min | $ -493.3M |
| max | $ 590.6M |
| average | $ 58.9M |
| median | $ 8.92M |
| std | $ 167.01M |